The present invention relates to substituted pyrazolopyridinamine compounds of general formula (I) as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyperproliferative, angiogenesis disorders, inflammatory diseases or diseases associated with inflammatory pain, as a sole agent or in combination with other active ingredients.
本发明涉及一般式(I)所述的取代
吡唑吡啶胺化合物,以及制备该化合物的方法,用于制备该化合物的中间化合物,包含该化合物的药物组合物和配方,以及利用该化合物制造用于治疗或预防疾病的药物组合物,特别是治疗过度增殖、血管生成障碍、炎症性疾病或与炎症性疼痛相关的疾病,作为唯一药物或与其他活性成分组合使用。